Physician profile
John J Bartolozzi
NPI 1366445876
$5,492.65
in general payments reported to CMS, 2019-2025
35 companies · $1,411 in 2025
The $1,411 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $560 · 2020: $178 · 2021: $509 · 2022: $700 · 2023: $1,027 · 2024: $1,108 · 2025: $1,411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,480 · Education: $66.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,479.87 |
| Education | $66.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $786.86 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $623.99 | 2021-2025 | Verquvo, Capvaxive |
| Pfizer INC. | $550.54 | 2019-2025 | |
| Amgen INC. | $529.83 | 2019-2025 | Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $507.63 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $477.49 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $278.29 | 2021-2025 | Cds Broad Portfolio Offering, Bodyguardian, Cds - Mct/Cem Monitoring |
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.36 | 2019-2024 | Jardiance |
| Abbott Laboratories | $186.52 | 2019-2023 | Mitraclip |
| Novo Nordisk INC | $158.03 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Esperion Therapeutics, INC. | $158.03 | 2020-2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $109.23 | 2019-2024 | Lifevest |
| Medtronic, INC. | $99.55 | 2023-2025 | Linq II, Azure Xt Dr Mri Surescan, Symplicity G3 |
| E.R. Squibb & Sons, L.L.C. | $89.42 | 2022-2025 | Camzyos, Eliquis |
| Kiniksa Pharmaceuticals, Ltd. | $86.72 | 2021-2023 | Arcalyst |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $82.55 | 2019-2021 | |
| Tactile Systems Technology INC | $69.52 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Shockwave Medical, INC | $42.81 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Scpharmaceuticals INC. | $40.66 | 2023 | |
| Philips North America LLC | $40.19 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $31.91 | 2024 | Arcalyst |
| Glaxosmithkline, LLC. | $31.07 | 2025 | Arexvy, Shingrix |
| Amarin Pharma, INC. | $30.90 | 2019-2020 | |
| Baxter Healthcare | $30.64 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Actelion Pharmaceuticals US, INC. | $22.01 | 2021 | |
| Biotronik INC. | $21.73 | 2024 | Orsiro Mission |
| Terumo Medical Corporation | $20.33 | 2020 | |
| Cvrx, INC. | $20.21 | 2024 | Barostim Neo System |
| Kestra Medical Technology Services, INC. | $19.74 | 2024 | Assure Wcd |
| Daiichi Sankyo INC. | $18.77 | 2024 | Injectafer |
| Medtronic Vascular, INC. | $18.76 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $16.60 | 2019 | |
| Irhythm Technologies, INC. | $15.34 | 2024 | Zio Xt Patch, Zio Monitor |
| Atricure, INC. | $14.49 | 2024 | |
| Allergan, INC. | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bartolozzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.